Steve Bauer, Ph.D., chief of the Cellular and Tissues Therapy Branch, Division of Cellular and Gene Therapies, in the Office of Cellular, Tissue and Gene Therapy at CBER.
By: Steve Bauer, Ph.D.
The Medical Device Business Journal — Medical Device News & Articles | MassDevice
By Lisa Fratt
By Tom Ulrich
Fitbit, Jawbone, Nike, Withings…a lot of companies are already in the wearable/mobile health technology and data tracking game. But a couple of really big players are stepping on to the court.
By Tom Ulrich
Ninety percent of lung cancer deaths are caused by the tumor’s spread – or metastasis – to other organs. Researchers have now discovered an approach to blocking metastasis in the most common type of lung cancer, adenocarcinoma, that potentially could be added to chemotherapy treatments aimed at shrinking the primary tumor.
By Tom Ulrich
It’s not every day you wake up and find out you’ve been named one of the most influential people in science. But that day recently came to seven Boston Children’s Hospital researchers, when Thomson Reuters named them as some of the most highly cited scientists in the world.
This morning the American Board of Medical Specialties’ (ABMS) Maintenance of Certification (MOC) program debate reached a larger mainstream media audience when the Wall Street Journalpublished their article by Melissa Beck entitled “Skill Reviews Upset Doctors.”
By Tom Ulrich
“How much pain are you in?” It’s a harder question than you think. Tools for assessing patients’ pain – be they children or adults – rely on their perception: a subjective measure that eludes quantification and can change in response to any number of emotional, psychological or physiological factors.